Abstract
The use of stem cells is considered a promising therapy for tissue regeneration and repair, particularly for tissues injured through degeneration, ischemia and inflammation. Bone marrow (BM)-derived haematopoietic stem cells (HSCs) are rare populations of multipotent stem cells that have been identified as promising potential candidates for treating a broad range of conditions. Although research into the use of stem cells for regenerative medicine is on a steep upward slope, clinical success has not been as forthcoming. This has been primarily attributed to a lack of information on the basic biology of stem cells, which remains insufficient to justify clinical studies. In particular, while our knowledge on the molecular adhesive mechanisms and local environmental factors governing stem cell homing to BM is detailed, our understanding of the mechanisms utilized at injured sites is very limited. For instance, it is unclear whether mechanisms used at injured sites are location specific or whether this recruitment can be modulated for therapeutic purposes. In addition, it has recently been suggested that platelets may play an important role in stem cell recruitment to sites of injury. A better understanding of the mechanisms used by stem cells during tissue homing would allow us to develop strategies to improve recruitment of these rare cells. This review will focus on the status of our current understanding of stem cell homing to injured tissues, the role of platelets and directions for the future.
Similar content being viewed by others
References
Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10344–10349.
Ferrari, G., Cusella-De Angelis, G., Coletta, M., et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279, 1528–1530.
Kale, S., Karihaloo, A., Clark, P. R., Kashgarian, M., Krause, D. S., & Cantley, L. G. (2003). Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. Journal of Clinical Investigation, 112, 42–49.
Lagasse, E., Connors, H., Al-Dhalimy, M., et al. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Natural Medicines, 6, 1229–1234.
Herzog, E. L., Chai, L., & Krause, D. S. (2003). Plasticity of marrow-derived stem cells. Blood, 102, 3483–3493.
Houlihan, D. D., & Newsome, P. N. (2008). Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology, 135, 438–450.
Ehnert, S., Glanemann, M., Schmitt, A., et al. (2009). The possible use of stem cells in regenerative medicine: dream or reality? Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie.
Strauer, B. E., & Kornowski, R. (2003). Stem cell therapy in perspective. Circulation, 107, 929–934.
Till, J. E., & Mc, C. E. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research, 14, 213–222.
Till, J. E., McCulloch, E. A., & Siminovitch, L. (1964). A Stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proceedings of the National Academy of Sciences of the United States of America, 51, 29–36.
Challen, G. A., Boles, N., Lin, K.-Y. K., & Goodell, M. A. (2009). Mouse hematopoietic stem cell identification and analysis. Cytometry. Part A, 75A, 14–24.
Massberg, S., Konrad, I., Schurzinger, K., et al. (2006). Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. The Journal of Experimental Medicine, 203, 1221–1233.
Wognum, A. W., Eaves, A. C., & Thomas, T. E. (2003). Identification and isolation of hematopoietic stem cells. Archives of Medical Research, 34, 461–475.
Balazs, A. B., Fabian, A. J., Esmon, C. T., & Mulligan, R. C. (2006). Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood, 107, 2317–2321.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of Experimental Medicine, 183, 1797–1806.
Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F., & Shaper, J. H. (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. Journal of Immunology, 133, 157–165.
Zanjani, E. D., Alemeida-Porada, G., Livingston, A. G., Flake, A. W., & Ogawa, M. (1998). Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Experimental Hematology, 26, 353–360.
Huss, R., Günther, W., Schumm, M., Ottinger, H., Grosse-Wilde, H., & Kolb, H. J. (1997). CD34-Negative Hematopoietic Stem Cells Isolated from Human Peripheral Blood Cells as Ultimate Precursors of Hematopoietic Progenitors. Transfusion Medicine and Hemotherapy, 24, 404–409.
Nakamura, Y., Ando, K., Chargui, J., et al. (1999). Ex Vivo generation of CD34+ cells from CD34- hematopoietic cells. Blood, 94, 4053–4059.
Gao, Z., Fackler, M. J., Leung, W., et al. (2001). Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. Experimental Hematology, 29, 910–921.
Osawa, M., Hanada, K., Hamada, H., & Nakauchi, H. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science, 273, 242–245.
Dalakas, E., Newsome, P. N., Liu, Q., et al. (2003). Mobilization of pluripotent haematopoietic stem cells occurs in alcoholic hepatitis and is associated with an improved clinical outcome. In. 55th Annual Meeting of the American Association for the Study of Liver Diseases. Hepatology, 284A.
Lemoli, R. M., Catani, L., Talarico, S., et al. (2006). Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells, 24, 2817–2825.
Sipkins, D. A., Wei, X., Wu, J. W., et al. (2005). In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature, 435, 969–973.
Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T., & Gronthos, S. (2005). Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 105, 3793–3801.
Petit, I., Szyper-Kravitz, M., Nagler, A., et al. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nature Immunology, 3, 687–694.
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Natural Medicines, 10, 858–864.
Kucia, M., Ratajczak, J., Reca, R., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2004). Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells, Molecules & Diseases, 32, 52–57.
Hattori, K., Heissig, B., Tashiro, K., et al. (2001). Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood, 97, 3354–3360.
Togel, F., Isaac, J., Hu, Z., Weiss, K., & Westenfelder, C. (2005). Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney International, 67, 1772–1784.
Terada, R., Yamamoto, K., Hakoda, T., et al. (2003). Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest, 83, 665–672.
Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., & Strieter, R. M. (2007). Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochemical and Biophysical Research Communications, 353, 104–108.
Zannettino, A. C., Farrugia, A. N., Kortesidis, A., et al. (2005). Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Research, 65, 1700–1709.
Hattori, K., Dias, S., Heissig, B., et al. (2001). Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. The Journal of Experimental Medicine, 193, 1005–1014.
Kollet, O., Shivtiel, S., Chen, Y. Q., et al. (2003). HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. Journal of Clinical Investigation, 112, 160–169.
Papayannopoulou, T., & Nakamoto, B. (1993). Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proceedings of the National Academy of Sciences of the United States of America, 90, 9374–9378.
Avigdor, A., Goichberg, P., Shivtiel, S., et al. (2004). CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood, 103, 2981–2989.
Xia, L., McDaniel, J. M., Yago, T., Doeden, A., & McEver, R. P. (2004). Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood, 104, 3091–3096.
Levesque, J. P., Takamatsu, Y., Nilsson, S. K., Haylock, D. N., & Simmons, P. J. (2001). Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood, 98, 1289–1297.
Nakano, Y., Kondo, T., Matsuo, R., Murata, S., Fukunaga, K., & Ohkohchi, N. (2009). Prevention of leukocyte activation by the neutrophil elastase inhibitor, sivelestat, in the hepatic microcirculation after ischemia-reperfusion. The Journal of Surgical Research, 155, 311–317.
Ferry, G., Lonchampt, M., Pennel, L., de Nanteuil, G., Canet, E., & Tucker, G. C. (1997). Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Letters, 402, 111–115.
Ramirez, P., Rettig, M. P., Uy, G. L., et al. (2009). BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood, 114, 1340–1343.
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Reviews. Immunology, 7, 678–689.
Turner, M. L., McIlwaine, K., Anthony, R. S., & Parker, A. C. (1995). Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized peripheral blood. Stem Cells, 13, 311–316.
Kobayashi, M., Imamura, M., Sakurada, K., et al. (1994). Expression of adhesion molecules on human hematopoietic progenitor cells at different maturation stages. Stem Cells, 12, 316.
Mazo, I. B., Gutierrez-Ramos, J., Frenette, P. S., Hynes, R. O., Wagner, D. D., & von Andrian, U. H. (1998). Hematopoietic progenitor cell rolling in bone marrow microvessels: Parrallel contributions by endothelial selectins and vascular cell adhesion molecule 1. The Journal of Experimental Medicine, 188, 465–474.
Frenette, P. S., Subbarao, S., Mazo, I. B., von Andrian, U. H., & Wagner, D. D. (1998). Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proceedings of the National Academy of Sciences of the United States of America, 95, 14423–14428.
Peled, A., Kollet, O., Ponomaryov, T., et al. (2000). The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood, 95, 3289–3296.
Hidalgo, A., & Frenette, P. S. (2005). Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood, 105, 567–575.
Zhang, S., Shpall, E., Willerson, J. T., & Yeh, E. T. (2007). Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circulation Research, 100, 693–702.
Kavanagh, D. P., Durant, L. E., Crosby, H. A., et al. (2009). Haematopoietic stem cell recruitment to injured murine liver sinusoids depends on {alpha}4{beta}1 integrin/VCAM-1 interactions. Gut, 59, 79–87.
Wong, J., Johnston, B., Lee, S. S., et al. (1997). A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. Journal of Clinical Investigation, 99, 2782–2790.
Clark, R. A., Alon, R., & Springer, T. A. (1996). CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. The Journal of Cell Biology, 134, 1075–1087.
Papayannopoulou, T., Priestley, G. V., Nakamoto, B., Zafiropoulos, V., & Scott, L. M. (2001). Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood, 98, 2403–2411.
Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G. V., & Wolf, N. S. (1995). The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proceedings of the National Academy of Sciences of the United States of America, 92, 9647–9651.
Jin, H., Aiyer, A., Su, J., et al. (2006). A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. Journal of Clinical Investigation, 116, 652–662.
Kimura, K., Nagaki, M., Kakimi, K., et al. (2008). Critical role of CD44 in hepatotoxin-mediated liver injury. Journal of Hepatology, 48, 952–961.
McDonald, B., McAvoy, E. F., Lam, F., et al. (2008). Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. The Journal of Experimental Medicine, 205, 915–927.
Chavakis, E., Urbich, C., & Dimmeler, S. (2008). Homing and engraftment of progenitor cells: a prerequisite for cell therapy. Journal of Molecular and Cellular Cardiology, 45, 514–522.
Kavanagh, D. P. J., Zhao, Y., Yemm, A. I., & Kalia, N. (2010). Mechansisms of hematopoeitic stem cell recruitment to injured Gut and Muscular microcircualtion [abstract]. Microcirculation, 17, 458–493.
Zhao, Y., Kavanagh, D. P., Thysse, J., Frampton, J., & Kalia, N. (2008). Factors contributing to haematopoietic stem cell recruitment to murine cremaster microcirculation [abstract PC71]. Microcirculation, 15, 633–687.
White, R. L., Mann, J., Kavanagh, D. P. J., Savage, C. O. S., & Kalia, N. (2010). Modulating the adhesion of Hematopoietic stem cells to ischemia-reperfusion injured kidney sections and identifictaion of the molecular mechanisms governing their adhesion [abstract]. Microcirculation, 17, 458–493.
Rocha, V., & Broxmeyer, H. E. (2010). New approaches for improving engraftment after cord blood transplantation. Biology of Blood and Marrow Transplantation, 16, S126–S132.
Zaruba, M. M., Theiss, H. D., Vallaster, M., et al. (2009). Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell, 4, 313–323.
Segers, V. F. M., Tokunou, T., Higgins, L. J., MacGillivray, C., Gannon, J., & Lee, R. T. (2007). Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation, 116, 1683–1692.
Zaruba, M. M., & Franz, W. M. (2010). Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opinion on Biological Therapy, 10, 321–335.
Stroo, I., Stokman, G., Teske, G. J., Florquin, S., & Leemans, J. C. (2009). Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1/CXCR4-axis. Nephrology, Dialysis, Transplantation, 24, 2082–2088.
Kavanagh, D. P. J. (2010). Molecular events governing hematopoietic stem cell recruitment in vivo in murine liver following Ischemia-reperfusion injury [PhD Thesis]: University of Birmingham. Accessible from http://etheses.bham.ac.uk/363/1/Kavanagh09PhD.pdf
Brenner, S., Whiting-Theobald, N., Kawai, T., et al. (2004). CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells, 22, 1128–1133.
Tarnowski, M., Liu, R., Wysoczynski, M., Ratajczak, J., Kucia, M., & Ratajczak, M. Z. (2010). CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. European Journal of Haematology, 85, 472–483.
Libert, F., Passage, E., Parmentier, M., Simons, M.-J., Vassart, G., & Mattei, M.-G. (1991). Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics, 11, 225–227.
Thelen, M., & Thelen, S. (2008). CXCR7, CXCR4 and CXCL12: an eccentric trio? Journal of Neuroimmunology, 198, 9–13.
Hartmann, T. N., Grabovsky, V., Pasvolsky, R., et al. (2008). A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. Journal of Leukocyte Biology, 84, 1130–1140.
Sierro, F., Biben, C., Martinez-Munoz, L., et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proceedings of the National Academy of Sciences of the United States of America, 104, 14759–14764.
Chavakis, E., Aicher, A., Heeschen, C., et al. (2005). Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. The Journal of Experimental Medicine, 201, 63–72.
Ryzhov, S., Solenkova, N. V., Goldstein, A. E., et al. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circulation Research, 102, 356–363.
Schoenhard, J. A., & Hatzopoulos, A. K. (2010). Stem Cell Therapy: Pieces of the Puzzle. Journal of cardiovascular translational research, 3, 49–60.
Sarkar, D., Vemula, P. K., Teo, G. S., et al. (2008). Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjugate Chemistry, 19, 2105–2109.
Varga-Szabo, D., Pleines, I., & Nieswandt, B. (2008). Cell adhesion mechanisms in platelets. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 403–412.
Langer, H., May, A. E., Daub, K., et al. (2006). Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circulation Research, 98, e2–e10.
de Boer, H. C., Verseyden, C., Ulfman, L. H., et al. (2006). Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1653–1659.
Stellos, K., Langer, H., Daub, K., et al. (2008). Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation, 117, 206–215.
Stellos, K., Bigalke, B., Langer, H., et al. (2009). Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. European Heart Journal, 30, 584–593.
Daub, K., Langer, H., Seizer, P., et al. (2006). Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. The FASEB Journal, 20, 2559–2561.
Peled, A., Grabovsky, V., Habler, L., et al. (1999). The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. Journal of Clinical Investigation, 104, 1199–1211.
Acknowledgements
DPJK is supported by the British Heart Foundation (PG/08/043). The work from our group detailed in this article was supported by grants from the British Heart Foundation (PG/08/043) and The Royal Society.
Conflict of Interest
The authors declare that there is no conflict of interest regarding the preparation or content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kavanagh, D.P.J., Kalia, N. Hematopoietic Stem Cell Homing to Injured Tissues. Stem Cell Rev and Rep 7, 672–682 (2011). https://doi.org/10.1007/s12015-011-9240-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-011-9240-z